GABELLI FUNDS LLC - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of CONMED CORP
ValueSharesWeighting
Q1 2023$3,247,807
-6.4%
2,640,000
-12.0%
0.02%
-7.4%
Q4 2022$3,468,030
+5.6%
3,000,0000.0%0.03%0.0%
Q3 2022$3,285,000
-9.5%
3,000,0000.0%0.03%
-3.6%
Q2 2022$3,628,000
-30.1%
3,000,0000.0%0.03%
-17.6%
Q1 2022$5,189,000
+3.8%
3,000,0000.0%0.03%
+6.2%
Q4 2021$5,000,000
+7.4%
3,000,0000.0%0.03%
+3.2%
Q3 2021$4,655,000
-4.1%
3,000,0000.0%0.03%0.0%
Q2 2021$4,853,000
+3.2%
3,000,0000.0%0.03%
-3.1%
Q1 2021$4,701,000
+11.7%
3,000,0000.0%0.03%
+6.7%
Q4 2020$4,207,000
+25.2%
3,000,0000.0%0.03%
+15.4%
Q3 2020$3,359,000
+7.0%
3,000,0000.0%0.03%0.0%
Q2 2020$3,140,000
+13.1%
3,000,0000.0%0.03%
+4.0%
Q1 2020$2,777,0003,000,0000.02%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 44,065,000$71,296,0007.64%
Mohican Financial Management, LLC 3,000,000$4,878,0001.90%
SHENKMAN CAPITAL MANAGEMENT INC 9,398,000$15,357,0001.40%
OSTERWEIS CAPITAL MANAGEMENT INC 8,930,000$14,433,0000.74%
SSI INVESTMENT MANAGEMENT LLC 6,454,000$10,396,0000.67%
MACKAY SHIELDS LLC 38,286,000$61,845,0000.58%
PALISADE CAPITAL MANAGEMENT, LP 5,208,000$8,417,0000.19%
Calamos Advisors LLC 23,085,000$37,345,0000.17%
Polar Asset Management Partners Inc. 10,000,000$16,168,0000.17%
Calamos Wealth Management LLC 1,026,000$1,660,0000.13%
View complete list of CONMED CORP shareholders